애플리케이션
EncapGel™ sustained release drug delivery hydrogel can be used for the encapsulation and delivery of drug or cells. The solution gels rapidly at 20 °C to 36 °C. Reverse thermal property of this hydrogel allows the percutaneous injection and immediate gelation in the body. The hydrogel matrix allows the spatial control of desired therapeutic agent in the vicinity of the target area. This hydrogel matrix is biodegraded completely within 3 days in-vivo, which allows the sustained release of the therapeutic agent to the targeted area. It is a research use only product to test the safety and efficacy of various therapeutic agents, such as drugs, small bioactive molecules, proteins, exosomes, targeted administration of micro- and nano-particles encapsulating therapeutic agents, or cellular-based therapeutics. This product is in a lyophilized powder form, and each vial can make 5 mL hydrogel.
포장
1.025 g in a glass vial
법적 정보
ENCAPGEL is a trademark of Sigma-Aldrich Co. LLC
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.